Data compiled by Redley Lamar · ChainSifter Intelligence
5Suppliers
5Customers
2Debt Items
20Related Chains
Source-Backed Evidence Depth
Jasper Therapeutics, Inc. (JSPR) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
13Total relationships
1Distinct source URLs
6High confidence
0.784Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Jasper Therapeutics, Inc. Suppliers
Ticker
Name
Confidence
Evidence
STANFORD
STANFORD
90%
Stanford transferred to the Company certain know-how and patents related to briquilimab
CIRM
CIRM
80%
The Company has received an aggregate of $ 2.3 million from CIRM through March 31, 2026
Reciprocal relationship from CLDX graph: Reciprocal relationship from JSPR graph: Reciprocal relationship from CLDX graph: Reciprocal relationship from JSPR graph: Reciprocal relationship from CLDX g…
Reciprocal relationship from SEPN graph: Reciprocal relationship from JSPR graph: Reciprocal relationship from SEPN graph: Reciprocal relationship from JSPR graph: Reciprocal relationship from SEPN g…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from JSPR graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from JSPR graph: Reciprocal relationship from SNYN…
Jasper Therapeutics, Inc. Customers
Ticker
Name
Confidence
Evidence
LONZA-SALES-AG
LONZA-SALES-AG
85%
ractices (“cGMP”) regulations for use in our clinical trials. The manufacture of pharmaceuticals is subject to extensive cGMP regulations, which impose various procedural and documentation requiremen…
Reciprocal relationship from CLDX graph: Reciprocal relationship from JSPR graph: h third parties to market and sell our product candidates, if approved, we may not be able to effectively market and …
Reciprocal relationship from GERN graph: Reciprocal relationship from JSPR graph: Reciprocal relationship from GERN graph: Reciprocal relationship from JSPR graph: Reciprocal relationship from GERN g…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from JSPR graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from JSPR graph: Reciprocal relationship from SNYN…
USA-LLC
USA-LLC
62%
l research to obtain regulatory approval is costly and time-consuming. The actual probability of success for our product candidates may be affected by a variety of factors, including the safety and e…
Jasper Therapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
JSPR-DEBT-10464
Warrants outstanding: 0.0001
90%
xbrl warrant detail from xbrl 2025-12-31.
JSPR-DEBT
Debt stack $757,000
90%
Market cache reports total debt of $757,000.
Jasper Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Jasper Therapeutics, Inc..
Jasper Therapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
JSPR-OWNER-MORGAN-STANLEY
MORGAN STANLEY
90%
13F overlay lists MORGAN STANLEY as top holder; 65 tracked holders.
Jasper Therapeutics, Inc. Extended Supply Chain Network
